LAUSANNE, Switzerland, February 20, 2018 /PRNewswire/ --
SOPHiA GENETICS, globalleader in Data-Driven Medicine, has been ranked 5th in Fast Company's Top 10 Most Innovative Companies in Biotech. The ranking recognizes companies that exemplify the best in business and innovation in their respective fields.
SOPHiA GENETICS' AI platform helps clinicians effectively diagnose and treat their patients. The company's Artificial Intelligence, SOPHiA, solves the complexity of genomic data analysis by accurately detecting disease-causing mutations in 5 disorders areas: hereditary cancer, oncology, cardiology, metabolism and pediatrics. To date, SOPHiA has been deployed across over 400 hospitals in 55 countries and has helped to better diagnose over 177'000 patients worldwide.
Fast Company's Top 10 lists recognize pioneering companies across 36 categories, from artificial intelligence to wellness. More than three dozen Fast Company editors, reporters, and contributors surveyed thousands of companies to create these lists.
ABOUT SOPHiA GENETICS
SOPHiA GENETICS: global leader in Data-Driven Medicine, SOPHiA GENETICS is a health tech company which has developed SOPHiA AI, the most advanced technology for clinical genomics, helping healthcare professionals better diagnose and treat patients. The global network of 410 institutions from 55 countries that use the SOPHiA DDMŪ analytical platform powered by SOPHiA form the world's largest clinical genomics community. By enabling the rapid adoption of genomic testing worldwide, turning data into actionable clinical insights, and sharing knowledge through its community, SOPHiA GENETICS is democratizing Data-Driven Medicine to save lives equally. The company's achievements were recognized by MIT Technology Review who ranked it amongst the 50 Smartest Companies in 2017. More info: http://www.sophiagenetics.com
SOPHiA GENETICS is on Twitter, follow @SOPHiAGENETICS
ABOUT FAST COMPANY
Fast Company is the world's leading progressive business media brand, with a unique editorial focus on innovation in technology, ethical economics, leadership, and design. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, one of the U.S.'s leading media companies.
SOURCE SOPHiA GENETICS
Subscribe to our Free Newsletters!
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...View All